Package 50991-740-02

{"route": ["ORAL"], "spl_id": "1cda4e52-f3cb-04b3-e063-6394a90a863f", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["9D2RTI9KYH", "495W7451VQ", "04JA59TNSJ"], "rxcui": ["2172190"], "spl_set_id": ["8aab8e5c-1633-2e5a-e053-2a95a90adcc5"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Poly Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (50991-740-01)", "package_ndc": "50991-740-01", "marketing_start_date": "20190601"}, {"sample": false, "description": "12 BLISTER PACK in 1 CARTON (50991-740-02)  / 1 TABLET in 1 BLISTER PACK", "package_ndc": "50991-740-02", "marketing_start_date": "20190601"}], "brand_name": "DECONEX DMX", "product_id": "50991-740_1cda4e52-f3cb-04b3-e063-6394a90a863f", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "50991-740", "generic_name": "Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride", "labeler_name": "Poly Pharmaceuticals, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "DECONEX", "brand_name_suffix": "DMX", "active_ingredients": [{"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "17.5 mg/1"}, {"name": "GUAIFENESIN", "strength": "400 mg/1"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": "10 mg/1"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20190601", "listing_expiration_date": "20261231"}